Metabolic profiling reveals potential biomarkers and underlying signaling pathways involved in mindfulness-based cognitive therapy-improved adolescent depression symptoms
Metabolisches Profiling zeigt potenzielle Biomarker und zugrunde liegende Signalwege bei der durch MBCT verbesserten depressiven Symptomatik bei Jugendlichen
EXCLI Journal · 05.01.2026 · 25 · 68-101
DOI: 10.17179/excli2025-8918 ↗Auf einen Blick
Bei 35 Jugendlichen unter MBCT veränderte sich das metabolische Profil gegenüber konventioneller Behandlung. Die Symptome von Angst und Depression verbesserten sich, und fünf Metabolite zeigten eine gute Vorhersage für die MBCT-Wirkung.
Fragestellung
Welche Metabolite und Stoffwechselwege sind mit einer Verbesserung depressiver Symptome durch MBCT bei Jugendlichen assoziiert?
Methode
Globales untargeted Metabolomics mit Plasma von 35 Jugendlichen mit Depression unter MBCT, 35 unter konventioneller Behandlung und 30 gesunden Kontrollen.
Ergebnisse
MBCT verbesserte SDS-, GAD-7- und SCL-90-Werte (P < 0,0001). Gegenüber CT waren 203 Metabolite erhöht und 186 erniedrigt (P < 0,05). Ein 5-Metabolit-Panel zeigte AUC = 0,9061.
Schlussfolgerung der Autor:innen
Die Autor:innen folgern, dass Arachidonsäure über den Long-term-depression-Signalweg eine zentrale Rolle bei der MBCT-Verbesserung jugendlicher Depression spielen könnte.
Kernaussagen
- MBCT verbesserte depressive und Angstsymptome
- 203 Metabolite waren erhöht, 186 erniedrigt
- 5 Metabolite zeigten AUC = 0,9061
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 05.01.2026. Verfasst von Chun-Hua Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Children and Adolescents, Anding Hospital Wuhu Hospital (Wuhu Fourth People's Hospital), Wuhu, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Mindfulness-based cognitive therapy (MBCT) demonstrates significant efficacy in improving depressive symptoms and modulating metabolic profiles. However, the specific metabolite biomarkers and metabolic pathways underlying MBCT's therapeutic effects in adolescent depression remain unclear. This study aims to identify potential metabolite biomarkers and metabolic regulation pathways associated with MBCT improvement of adolescent depression. A global untargeted metabolomics approach was employed to analyze plasma samples from 35 adolescents with depression undergoing MBCT, 35 receiving conventional treatment (CT), and 30 age- and sex-matched healthy controls. MBCT significantly alleviated anxiety and depression symptoms of adolescent patients visualized by SDS, GAD-7, and SCL-90 scores (P < 0.0001). Untargeted metabolomics analysis revealed distinct metabolic profile changes in MBCT group compared to CT group, with 203 metabolites significantly upregulated and 186 significantly downregulated in MBCT group (P < 0.05). Notably, circulating levels of metabolites such as 10,11-epoxy-3-geranylgeranylindole and paspalicine showed marked increases (P < 0.05), whereas abundances of arachidonic acid and L-glutamic acid exhibited significant decreases (P < 0.05). KEGG pathway enrichment analysis indicated that the 186 downregulated metabolites were primarily enriched in pathways such as long-term depression, synaptic vesicle cycle, GnRH signaling, and aspartate and glutamate metabolism. Pearson’s correlation analysis suggested that arachidonic acid level changes was significantly correlated with clinical improvement of SDS and SCL-90 scores (adjusted P < 0.05). ROC analysis revealed that a combination of five metabolites, including 10,11-epoxy-3-geranylgeranylindole, (1S,2R)-1-C-(indol-3-yl) glycerol 3-phosphate, paspalicine, FO 2546E, and FO 2546M, exhibited strong predictive potential for MBCT efficacy (AUC = 0.9061). These findings suggested that arachidonic acid involved in the long-term depression pathway may play pivotal roles in MBCT improvement of adolescent depression. This study provides insight into the potential biomarkers and metabolic regulation mechanisms underlying MBCT's therapeutic effects and theoretical guidance for clinical practice in MBCT intervention for adolescent depression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Children and Adolescents, Anding Hospital Wuhu Hospital (Wuhu Fourth People's Hospital), Wuhu, China.
- Department of Nursing, Anding Hospital Wuhu Hospital (Wuhu Fourth People's Hospital), Wuhu, China.
- Department of Psychology, Anding Hospital Wuhu Hospital (Wuhu Fourth People's Hospital), Wuhu, China.
- The Research Center for Lin He Academician New Medicine, Institutes for Shanghai Pudong Decoding Life, Shanghai, China.
- Lishui Key Laboratory of Brain Health and Severe Brain Disorders, Lishui Second People's Hospital Affiliated to Wenzhou Medical University, Lishui, China.
- Department of Children and Adolescents, Lishui Second People's Hospital Affiliated to Wenzhou Medical University, Lishui, China.
Zitieren
APA
Xu, C. H., Zhang, B. L., Guan, C. L., Wang, L., Chao, S., Li, H., Wu, Q. P., Zhou, D. J., Min, G. Q., & Yang, F. (2026). Metabolic profiling reveals potential biomarkers and underlying signaling pathways involved in mindfulness-based cognitive therapy-improved adolescent depression symptoms. EXCLI Journal, 25, 68-101. https://doi.org/10.17179/excli2025-8918
Vancouver
Xu CH, Zhang BL, Guan CL, Wang L, Chao S, Li H, et al. Metabolic profiling reveals potential biomarkers and underlying signaling pathways involved in mindfulness-based cognitive therapy-improved adolescent depression symptoms. EXCLI Journal. 2026;25:68-101. doi:10.17179/excli2025-8918
BibTeX
@article{Xu2026,
author = {Xu, Chun-Hua and Zhang, Bi-Lan and Guan, Chun-Lan and Wang, Lin and Chao, Shan and Li, He and Wu, Qiu-Ping and Zhou, Da-Jin and Min, Guo-Qing and Yang, Fan},
title = {Metabolic profiling reveals potential biomarkers and underlying signaling pathways involved in mindfulness-based cognitive therapy-improved adolescent depression symptoms},
journal = {EXCLI Journal},
year = {2026},
volume = {25},
pages = {68--101},
doi = {10.17179/excli2025-8918}
}
EUVIMED